Spatiotemporal architecture of immune cells and cancer-associated fibroblasts in high-grade serous ovarian carcinoma
Science Advances · 19.04.2024 · 10 (16)
DOI: 10.1126/sciadv.adk8805 ↗Kurz gefasst
Fachartikel in der Zeitschrift Science Advances, erschienen am 19.04.2024. Verfasst von Alexander M Xu und 7 weiteren Autor:innen. Beteiligte Einrichtung: Board of Governors Regenerative Medicine Institute, Cedars-Sinai Medical Center, Los Angeles, CA 90048, USA. Hauptthemen laut MEDLINE: Cancer-Associated Fibroblasts, Antineoplastic Agents, Ovarian Neoplasms. Die Arbeit wurde bisher 43-mal zitiert (Crossref) und nennt 106 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: BLRD VA, NCI NIH HHS, NCATS NIH HHS.
Abstract (Originalsprache)
High-grade serous ovarian carcinoma (HGSOC), the deadliest form of ovarian cancer, is typically diagnosed after it has metastasized and often relapses after standard-of-care platinum-based chemotherapy, likely due to advanced tumor stage, heterogeneity, and immune evasion and tumor-promoting signaling from the tumor microenvironment. To understand how spatial heterogeneity contributes to HGSOC progression and early relapse, we profiled an HGSOC tissue microarray of patient-matched longitudinal samples from 42 patients. We found spatial patterns associated with early relapse, including changes in T cell localization, malformed tertiary lymphoid structure (TLS)–like aggregates, and increased podoplanin-positive cancer-associated fibroblasts (CAFs). Using spatial features to compartmentalize the tissue, we found that plasma cells distribute in two different compartments associated with TLS-like aggregates and CAFs, and these distinct microenvironments may account for the conflicting reports about the role of plasma cells in HGSOC prognosis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Board of Governors Regenerative Medicine Institute, Cedars-Sinai Medical Center, Los Angeles, CA 90048, USA.
- Division of Hematology and Cellular Therapy, Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, CA 90048, USA.
- Department of Obstetrics and Gynecology and Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, CA 90048, USA.
- Department of Pathology and Laboratory Medicine, Cedars-Sinai Medical Center, Los Angeles, CA 90048, USA.
- Department of Obstetrics and Gynecology, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, CA 90095, USA.
- Department of Veterans Affairs, Greater Los Angeles Healthcare System, Los Angeles, CA 90073, USA.
ORCID-Profile: Alexander M Xu, Ann E Walts, Beth Y Karlan, Akil Merchant, Sandra Orsulic
Förderung
- BLRD VA
- NCI NIH HHS
- NCATS NIH HHS
Zitieren
APA
Xu, A. M., Haro, M., Walts, A. E., Hu, Y., John, J., Karlan, B. Y., Merchant, A., & Orsulic, S. (2024). Spatiotemporal architecture of immune cells and cancer-associated fibroblasts in high-grade serous ovarian carcinoma. Science Advances, 10(16). https://doi.org/10.1126/sciadv.adk8805
Vancouver
Xu AM, Haro M, Walts AE, Hu Y, John J, Karlan BY, et al. Spatiotemporal architecture of immune cells and cancer-associated fibroblasts in high-grade serous ovarian carcinoma. Science Advances. 2024;10(16). doi:10.1126/sciadv.adk8805
BibTeX
@article{Xu2024,
author = {Xu, Alexander M and Haro, Marcela and Walts, Ann E and Hu, Ye and John, Joshi and Karlan, Beth Y and Merchant, Akil and Orsulic, Sandra},
title = {Spatiotemporal architecture of immune cells and cancer-associated fibroblasts in high-grade serous ovarian carcinoma},
journal = {Science Advances},
year = {2024},
volume = {10},
number = {16},
doi = {10.1126/sciadv.adk8805}
}
EUVIMED